Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading
AD LSEG Data AD CME Group Education AD Bank of England Statistics AD Investing.com Markets
City & Markets

Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval

City noticeboard, Trade Hub UK (2026-11-09): Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity. Primary source: original at CNBC Top News (cnbc.com).

By CNBC Top News

Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval

Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.

Read at source

Read also
  1. A failed trial for a heart drug casts shadow over rivals developing similar therapies
  2. Should a widow leave her late partner’s home to her stepkids — or cut off contact with them?
  3. From supermarket fridges to passenger flights, a wave of threats is testing Europe's defenses
  4. How SpaceX was able to avert one of the market’s biggest fears about its stock
  5. Nvidia stock falls 5% as scrutiny turns to Jensen Huang’s relationship with alleged Chinese spy

Source: CNBC Top News